For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Optimer Pharmaceuticals, Inc.

USPTO Granted Patents = 16

% Expired Patents = 31.3

CIPO Patents = 4

EPO Patents = 2

Trademarks = 1

Forward Citations = 89

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Youe-Kong Shue (15 out of 16 patents)

Yu-Hung Chiu (11 out of 12 patents)

Yoshi Ichikawa (9 out of 9 patents)

4. Alex Romero (8 out of 9 patents)

5. Chan-Kou Hwang (5 out of 13 patents)

6. Farah Kondori Babakhani (5 out of 5 patents)

7. Tessie Mary Che (5 out of 5 patents)

8. Jonathan James Duffield (5 out of 6 patents)

9. Franklin W Okumu (4 out of 25 patents)

10. Yoshitaka Ichikawa (2 out of 10 patents)

11. Chi-Jen Frank Du (2 out of 2 patents)

12. Mei-Chiao Wu (2 out of 2 patents)

13. Yuan-Ting Chen (2 out of 2 patents)

14. Pamela Sears (2 out of 2 patents)

15. David Rabuka (1 out of 41 patents)

16 patents: Sort by Forward Citations

1. 8916527 - Antibiotic macrocycle compounds and methods of manufacture and use thereof (2014-12-23),

2. 8883986 - Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof (2014-11-11),

3. 8859510 - Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof (2014-10-14),

4. 8728796 - Tiacumicin production (2014-05-20),

5. 8586551 - 18-membered macrocycles and analogs thereof (2013-11-19),

6. 8518899 - Macrocyclic polymorphs, compositions comprising such polymorphs and methods of use and manufacture thereof (2013-08-27),

7. 8445654 - Antibiotic macrocycle compounds and methods of manufacture and use thereof (2013-05-21),

8. 8343936 - Antibacterial agents (2013-01-01),

9. 8044030 - Antibiotic macrocycle compounds and methods of manufacture and use thereof (2011-10-25),

10. 8012943 - Antibacterial agents (2011-09-06),

11. 7906489 - 18-membered macrocycles and analogs thereof (2011-03-15),

12. 7863249 - Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof (2011-01-04),

13. 7601695 - Antibacterial agents (2009-10-13),

14. 7507564 - Tiacumicin production (2009-03-24),

15. 7414885 - Method and apparatus for reading data from a ferromagnetic memory cell (2008-08-19),

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative anti-infective products to treat serious infections. With a commitment to improving patient care, Optimer has developed a revolutionary drug called Dificid® (fidaxomicin), which targets and treats Clostridioides difficile infection (CDI) – a highly prevalent and severe bacterial infection. With a dedication to research and development, Optimer continues to explore novel therapies to address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

16 Patents

#43 in Lexington, MA

#1,202 in Massachusetts

#19,887 in US

#37,739 in the World

Lexington, MA, United States of America

Optimer Pharmaceuticals, Inc.

Forward Citations = 89

22 inventors:

Youe-Kong Shue (15 out of 16 patents)

Yu-Hung Chiu (11 out of 12 patents)

Yoshi Ichikawa (9 out of 9 patents)

4. Alex Romero (8 out of 9 patents)

5. Chan-Kou Hwang (5 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…